| 000 | 01581 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518033652.0 | ||
| 264 | 0 | _c20200205 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a2326-5205 | ||
| 024 | 7 |
_a10.1002/art.40892 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKitas, George D | |
| 245 | 0 | 0 |
_aA Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis. _h[electronic resource] |
| 260 |
_bArthritis & rheumatology (Hoboken, N.J.) _c09 2019 |
||
| 300 |
_a1437-1449 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xblood |
| 650 | 0 | 4 |
_aAtorvastatin _xtherapeutic use |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xetiology |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrimary Prevention _xmethods |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aNightingale, Peter | |
| 700 | 1 | _aArmitage, Jane | |
| 700 | 1 | _aSattar, Naveed | |
| 700 | 1 | _aBelch, Jill J F | |
| 700 | 1 | _aSymmons, Deborah P M | |
| 773 | 0 |
_tArthritis & rheumatology (Hoboken, N.J.) _gvol. 71 _gno. 9 _gp. 1437-1449 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.40892 _zAvailable from publisher's website |
| 999 |
_c29586830 _d29586830 |
||